Efficacy and safety of nabumetone in 5,421 patients with osteoarthritis of the hip and/or knee joints. A subgroup evaluation of an outpatient study involving 18,047 patients
- PMID: 2081500
- DOI: 10.2165/00003495-199000405-00019
Efficacy and safety of nabumetone in 5,421 patients with osteoarthritis of the hip and/or knee joints. A subgroup evaluation of an outpatient study involving 18,047 patients
Similar articles
-
Double-blind crossover study of nabumetone versus naproxen in the treatment of osteoarthritis of the knee and hip.J Int Med Res. 1982;10(4):209-13. doi: 10.1177/030006058201000403. J Int Med Res. 1982. PMID: 7117677 Clinical Trial.
-
[A non-steroidal antirheumatic agent (nabumetone): effectiveness and tolerance in short and long-term use].Z Rheumatol. 1983 Mar-Apr;42(2):82-5. Z Rheumatol. 1983. PMID: 6410605 Clinical Trial. German.
-
Efficacy and safety of nabumetone in patients with rheumatic diseases. Results of an outpatient study involving 8,865 patients.Drugs. 1990;40 Suppl 5:50-2. doi: 10.2165/00003495-199000405-00012. Drugs. 1990. PMID: 2081493 Clinical Trial. No abstract available.
-
Nabumetone (Relifex)--another NSAID.Drug Ther Bull. 1988 May 31;26(11):41-3. doi: 10.1136/dtb.26.11.41. Drug Ther Bull. 1988. PMID: 3289871 Review. No abstract available.
-
Efficacy and improved safety--a new anti-arthritic agent.Eur J Rheumatol Inflamm. 1991;11(3):43-9. Eur J Rheumatol Inflamm. 1991. PMID: 1365480 Review.
Cited by
-
Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.Drugs. 1993 Jan;45(1):131-56. doi: 10.2165/00003495-199345010-00009. Drugs. 1993. PMID: 7680981
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
